Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 6, Pages e39942
Publisher
Public Library of Science (PLoS)
Online
2012-06-30
DOI
10.1371/journal.pone.0039942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, -Synuclein Accumulation, and Neurotoxicity
- (2012) M. Usenovic et al. JOURNAL OF NEUROSCIENCE
- ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome
- (2012) Anne Grünewald et al. NEUROBIOLOGY OF AGING
- Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death
- (2011) Janet Ugolino et al. HUMAN MOLECULAR GENETICS
- PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity
- (2011) David Ramonet et al. HUMAN MOLECULAR GENETICS
- Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism
- (2011) Jin-Sung Park et al. HUMAN MUTATION
- Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein
- (2011) Jieqiong Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ATP13A2 regulates mitochondrial bioenergetics through macroautophagy
- (2011) Aaron M. Gusdon et al. NEUROBIOLOGY OF DISEASE
- Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
- (2011) David Ramonet et al. PLoS One
- Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome
- (2010) A. S. Al-Din et al. ACTA NEUROLOGICA SCANDINAVICA
- Vesicular distribution of Secretory Pathway Ca2+-ATPase isoform 1 and a role in manganese detoxification in liver-derived polarized cells
- (2010) Sharon Leitch et al. BIOMETALS
- Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations
- (2010) Maria I. Behrens et al. MOVEMENT DISORDERS
- ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation
- (2010) Susanne A. Schneider et al. MOVEMENT DISORDERS
- Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability
- (2010) Lucio Santoro et al. NEUROGENETICS
- Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation
- (2010) David Crosiers et al. PARKINSONISM & RELATED DISORDERS
- Identification of a gain-of-function mutation in a Golgi P-type ATPase that enhances Mn2+ efflux and protects against toxicity
- (2010) S. Mukhopadhyay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2
- (2009) Karyn Schmidt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mendelian forms of Parkinson's disease
- (2009) Thomas Gasser BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
- (2009) Aaron D Gitler et al. NATURE GENETICS
- Parkin mediates the degradation-independent ubiquitination of Hsp70
- (2008) Darren J. Moore et al. JOURNAL OF NEUROCHEMISTRY
- Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore
- (2008) C. H. Lin et al. NEUROLOGY
- PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE
- (2008) Y. P. Ning et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now